Cargando…

Synergistic sequence contributions bias glycation outcomes

The methylglyoxal-derived hydroimidazolone isomer, MGH-1, is an abundant advanced glycation end-product (AGE) associated with disease and age-related disorders. As AGE formation occurs spontaneously and without an enzyme, it remains unknown why certain sites on distinct proteins become modified with...

Descripción completa

Detalles Bibliográficos
Autores principales: McEwen, Joseph M., Fraser, Sasha, Guir, Alexxandra L. Sosa, Dave, Jaydev, Scheck, Rebecca A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175500/
https://www.ncbi.nlm.nih.gov/pubmed/34083524
http://dx.doi.org/10.1038/s41467-021-23625-8
_version_ 1783703064052498432
author McEwen, Joseph M.
Fraser, Sasha
Guir, Alexxandra L. Sosa
Dave, Jaydev
Scheck, Rebecca A.
author_facet McEwen, Joseph M.
Fraser, Sasha
Guir, Alexxandra L. Sosa
Dave, Jaydev
Scheck, Rebecca A.
author_sort McEwen, Joseph M.
collection PubMed
description The methylglyoxal-derived hydroimidazolone isomer, MGH-1, is an abundant advanced glycation end-product (AGE) associated with disease and age-related disorders. As AGE formation occurs spontaneously and without an enzyme, it remains unknown why certain sites on distinct proteins become modified with specific AGEs. Here, we use a combinatorial peptide library to determine the chemical features that favor MGH-1. When properly positioned, tyrosine is found to play an active mechanistic role that facilitates MGH-1 formation. This work offers mechanistic insight connecting multiple AGEs, including MGH-1 and carboxyethylarginine (CEA), and reconciles the role of negative charge in influencing glycation outcomes. Further, this study provides clear evidence that glycation outcomes can be influenced through long- or medium-range cooperative interactions. This work demonstrates that these chemical features also predictably template selective glycation on full-length protein targets expressed in mammalian cells. This information is vital for developing methods that control glycation in living cells and will enable the study of glycation as a functional post-translational modification.
format Online
Article
Text
id pubmed-8175500
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81755002021-06-07 Synergistic sequence contributions bias glycation outcomes McEwen, Joseph M. Fraser, Sasha Guir, Alexxandra L. Sosa Dave, Jaydev Scheck, Rebecca A. Nat Commun Article The methylglyoxal-derived hydroimidazolone isomer, MGH-1, is an abundant advanced glycation end-product (AGE) associated with disease and age-related disorders. As AGE formation occurs spontaneously and without an enzyme, it remains unknown why certain sites on distinct proteins become modified with specific AGEs. Here, we use a combinatorial peptide library to determine the chemical features that favor MGH-1. When properly positioned, tyrosine is found to play an active mechanistic role that facilitates MGH-1 formation. This work offers mechanistic insight connecting multiple AGEs, including MGH-1 and carboxyethylarginine (CEA), and reconciles the role of negative charge in influencing glycation outcomes. Further, this study provides clear evidence that glycation outcomes can be influenced through long- or medium-range cooperative interactions. This work demonstrates that these chemical features also predictably template selective glycation on full-length protein targets expressed in mammalian cells. This information is vital for developing methods that control glycation in living cells and will enable the study of glycation as a functional post-translational modification. Nature Publishing Group UK 2021-06-03 /pmc/articles/PMC8175500/ /pubmed/34083524 http://dx.doi.org/10.1038/s41467-021-23625-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
McEwen, Joseph M.
Fraser, Sasha
Guir, Alexxandra L. Sosa
Dave, Jaydev
Scheck, Rebecca A.
Synergistic sequence contributions bias glycation outcomes
title Synergistic sequence contributions bias glycation outcomes
title_full Synergistic sequence contributions bias glycation outcomes
title_fullStr Synergistic sequence contributions bias glycation outcomes
title_full_unstemmed Synergistic sequence contributions bias glycation outcomes
title_short Synergistic sequence contributions bias glycation outcomes
title_sort synergistic sequence contributions bias glycation outcomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175500/
https://www.ncbi.nlm.nih.gov/pubmed/34083524
http://dx.doi.org/10.1038/s41467-021-23625-8
work_keys_str_mv AT mcewenjosephm synergisticsequencecontributionsbiasglycationoutcomes
AT frasersasha synergisticsequencecontributionsbiasglycationoutcomes
AT guiralexxandralsosa synergisticsequencecontributionsbiasglycationoutcomes
AT davejaydev synergisticsequencecontributionsbiasglycationoutcomes
AT scheckrebeccaa synergisticsequencecontributionsbiasglycationoutcomes